CD8+ T cells are activated in an antigen-independent manner in HIV-infected individuals

Journal of Immunology

Volumn 192, Issue 4, 2014, Pages 1732-1744

  Bastidas, Sonia ^a   Graw, Frederik ^a,c   Smith, Miranda Z ^a,d   Kuster, Herbert ^b   Günthard, Huldrych F ^b   Oxenius, Annette ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTI-HIV AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DENDRITIC CELLS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-15; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED;

EID: 84894247943     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302027     Document Type: Article

References (71)

1. Giorgi, J. V., L. E. Hultin, J. A. McKeating, T. D. Johnson, B. Owens, L. P. Jacobson, R. Shih, J. Lewis, D. J. Wiley, J. P. Phair, et al. 1999. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J. Infect. Dis. 179: 859-870.
2. Sousa, A. E., J. Carneiro, M. Meier-Schellersheim, Z. Grossman, and R. M. Victorino. 2002. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J. Immunol. 169: 3400-3406.
3. Doisne, J. M., A. Urrutia, C. Lacabaratz-Porret, C. Goujard, L. Meyer, M. L. Chaix, M. Sinet, and A. Venet. 2004. CD8+ T cells specific for EBV, cytomegalovirus, and influenza virus are activated during primary HIV infection. J. Immunol. 173: 2410-2418.
4. Betts, M. R., D. R. Ambrozak, D. C. Douek, S. Bonhoeffer, J. M. Brenchley, J. P. Casazza, R. A. Koup, and L. J. Picker. 2001. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75: 11983-11991.
5. Migueles, S. A., A. C. Laborico, W. L. Shupert, M. S. Sabbaghian, R. Rabin, C. W. Hallahan, D. Van Baarle, S. Kostense, F. Miedema, M. McLaughlin, et al. 2002. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol. 3: 1061-1068.
6. Chen, G., P. Shankar, C. Lange, H. Valdez, P. R. Skolnik, L. Wu, N. Manjunath, and J. Lieberman. 2001. CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection. Blood 98: 156-164.
7. Bangs, S. C., A. J. McMichael, and X. N. Xu. 2006. Bystander T cell activation - implications for HIV infection and other diseases. Trends Immunol. 27: 518-524.
8. Appay, V., and D. Sauce. 2008. Immune activation and inflammation in HIV-1 infection: causes and consequences. J. Pathol. 214: 231-241.
9. Bangs, S. C., D. Baban, H. J. Cattan, C. K.-F. Li, A. J. McMichael, and X.-N. Xu. 2009. Human CD4+ memory T cells are preferential targets for bystander activation and apoptosis. J. Immunol. 182: 1962-1971.
10. Brenchley, J. M., D. A. Price, T. W. Schacker, T. E. Asher, G. Silvestri, S. Rao, Z. Kazzaz, E. Bornstein, O. Lambotte, D. Altmann, et al. 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12: 1365-1371.
11. Biancotto, A., J. C. Grivel, S. J. Iglehart, C. Vanpouille, A. Lisco, S. F. Sieg, R. Debernardo, K. Garate, B. Rodriguez, L. B. Margolis, and M. M. Lederman. 2007. Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. Blood 109: 4272-4279.
12. Haas, A., M. Rehr, F. Graw, P. Rusert, W. Bossart, H. Kuster, A. Trkola, H. F. Günthard, and A. Oxenius. 2010. HIV-1 replication activates CD4+ T cells with specificities for persistent herpes viruses. EMBO Mol. Med 2: 231-244.
13. Smith, M. Z., S. Bastidas, U. Karrer, and A. Oxenius. 2013. Impact of antigen specificity on CD4+ T cell activation in chronic HIV-1 infection. BMC Infect. Dis. 13: 100.
14. Wyl, Vv., S. Gianella, M. Fischer, B. Niederoest, H. Kuster, M. Battegay, E. Bernasconi, M. Cavassini, A. Rauch, B. Hirschel, et al; Swiss HIV Cohort Study-SHCS. 2011. Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption. PLoS ONE 6: e27463.
15. Rieder, P., B. Joos, A. U. Scherrer, H. Kuster, D. Braun, C. Grube, B. Niederost, C. Leemann, S. Gianella, K. J. Metzner, J. Boni, R. Weber, and H. F. Gunthard. 2011. Characterization of human immunodeficiency virus type 1 (HIV-1) diversity and tropism in 145 patients with primary HIV-1 infection. Clin. Infect. Dis. 53: 1271-1279.
16. Gianella, S., V. von Wyl, M. Fischer, B. Niederoest, M. Battegay, E. Bernasconi, M. Cavassini, A. Rauch, B. Hirschel, P. Vernazza, et al; Swiss HIV Cohort Study. 2011. Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA. Antivir. Ther. (Lond.) 16: 535-545.
17. Kouyos, R. D., V. vonWyl, S. Yerly, J. Boni, P. Rieder, B. Joos, P. Taffe, C. Shah, P. Burgisser, T. Klimkait, R. Weber, B. Hirschel, M. Cavassini, A. Rauch, M. Battegay, P. L. Vernazza, E. Bernasconi, B. Ledergerber, S. Bonhoeffer, H. F. Gunthard, and H. I. V. C. S. Swiss. 2011. Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection. Clin. Infect. Dis. 52: 532-539.
18. Schmid, A., S. Gianella, V. von Wyl, K. J. Metzner, A. U. Scherrer, B. Niederöst, C. F. Althaus, P. Rieder, C. Grube, B. Joos, et al. 2010. Profound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infection. PLoS ONE 5: e13310.
19. Harman, A. N., J. Wilkinson, C. R. Bye, L. Bosnjak, J. L. Stern, M. Nicholle, J. Lai, and A. L. Cunningham. 2006. HIV induces maturation of monocytederived dendritic cells and Langerhans cells. J. Immunol. 177: 7103-7113.
20. Oxenius, A., D. A. Price, P. J. Easterbrook, C. A. O'Callaghan, A. D. Kelleher, J. A. Whelan, G. Sontag, A. K. Sewell, and R. E. Phillips. 2000. Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes. Proc. Natl. Acad. Sci. USA 97: 3382-3387.
21. Hislop, A. D., G. S. Taylor, D. Sauce, and A. B. Rickinson. 2007. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu. Rev. Immunol. 25: 587-617.
22. Assarsson, E., H. H. Bui, J. Sidney, Q. Zhang, J. Glenn, C. Oseroff, I. N. Mbawuike, J. Alexander, M. J. Newman, H. Grey, and A. Sette. 2008. Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans. J. Virol. 82: 12241-12251.
23. Rossio, J. L., M. T. Esser, K. Suryanarayana, D. K. Schneider, J. W. Bess, Jr., G. M. Vasquez, T. A. Wiltrout, E. Chertova, M. K. Grimes, Q. Sattentau, et al. 1998. Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. J. Virol. 72: 7992-8001.
24. Goriely, S., B. Vincart, P. Stordeur, J. Vekemans, F. Willems, M. Goldman, and D. De Wit. 2001. Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes. J. Immunol. 166: 2141-2146.
25. Kebelmann-Betzing, C., G. Körner, L. Badiali, D. Buchwald, A. Möricke, A. Korte, J. Köchling, S. Wu, D. Kappelmeier, K. Oettel, et al. 2001. Characterization of cytokine, growth factor receptor, costimulatory and adhesion molecule expression patterns of bone marrow blasts in relapsed childhood B cell precursor all. Cytokine 13: 39-50.
26. Dubin, J. A., and H. G. Müller. 2005. Dynamical correlation for multivariate longitudinal data. J. Am. Stat. Assoc. 100: 872-881.
27. Stacey, A. R., P. J. Norris, L. Qin, E. A. Haygreen, E. Taylor, J. Heitman, M. Lebedeva, A. DeCamp, D. Li, D. Grove, et al. 2009. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J. Virol. 83: 3719-3733.
28. Stonier, S. W., and K. S. Schluns. 2010. Trans-presentation: a novel mechanism regulating IL-15 delivery and responses. Immunol. Lett. 127: 85-92.
29. Do, J. S., and B. Min. 2009. IL-15 produced and trans-presented by DCs underlies homeostatic competition between CD8 and gammadelta T cells in vivo. Blood 113: 6361-6371.
30. Mattei, F., G. Schiavoni, F. Belardelli, and D. F. Tough. 2001. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J. Immunol. 167: 1179-1187.
31. Estes, J. D., L. D. Harris, N. R. Klatt, B. Tabb, S. Pittaluga, M. Paiardini, G. R. Barclay, J. Smedley, R. Pung, K. M. Oliveira, et al. 2010. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog. 6: e1001052.
32. Sodora, D. L., and G. Silvestri. 2008. Immune activation and AIDS pathogenesis. AIDS 22: 439-446.
33. Deeks, S. G., C. M. Kitchen, L. Liu, H. Guo, R. Gascon, A. B. Narváez, P. Hunt, J. N. Martin, J. O. Kahn, J. Levy, et al. 2004. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104: 942-947.
34. Hazenberg, M. D., S. A. Otto, B. H. van Benthem, M. T. Roos, R. A. Coutinho, J. M. Lange, D. Hamann, M. Prins, and F. Miedema. 2003. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 17: 1881-1888.
35. Fahey, J. L., J. M. Taylor, B. Manna, P. Nishanian, N. Aziz, J. V. Giorgi, and R. Detels. 1998. Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements. AIDS 12: 1581-1590.
36. Douek, D. C. 2003. Disrupting T-cell homeostasis: how HIV-1 infection causes disease. AIDS Rev. 5: 172-177.
37. Silvestri, G., D. L. Sodora, R. A. Koup, M. Paiardini, S. P. O'Neil, H. M. McClure, S. I. Staprans, and M. B. Feinberg. 2003. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 18: 441-452.
38. Grossman, Z., M. Meier-Schellersheim, W. E. Paul, and L. J. Picker. 2006. Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat. Med. 12: 289-295.
39. Bofill, M., A. Mocroft, M. Lipman, E. Medina, N. J. Borthwick, C. A. Sabin, A. Timms, M. Winter, L. Baptista, M. A. Johnson, et al. 1996. Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients. AIDS 10: 827-834.
40. Wilson, C. M., J. H. Ellenberg, S. D. Douglas, A. B. Moscicki, and C. A. Holland; Reach Project Of The Adolescent Medicine HIV/AIDS Research Network. 2004. CD8+CD38+ T cells but not HIV type 1 RNA viral load predict CD4+ T cell loss in a predominantly minority female HIV+ adolescent population. AIDS Res. Hum. Retroviruses 20: 263-269.
41. Hazenberg, M. D., J. W. Stuart, S. A. Otto, J. C. Borleffs, C. A. Boucher, R. J. de Boer, F. Miedema, and D. Hamann. 2000. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 95: 249-255.
42. Catalfamo, M., M. Di Mascio, Z. Hu, S. Srinivasula, V. Thaker, J. Adelsberger, A. Rupert, M. Baseler, Y. Tagaya, G. Roby, et al. 2008. HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells. Proc. Natl. Acad. Sci. USA 105: 19851-19856.
43. Catalfamo, M., C. Wilhelm, L. Tcheung, M. Proschan, T. Friesen, J. H. Park, J. Adelsberger, M. Baseler, F. Maldarelli, R. Davey, et al. 2011. CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis, HIV, type I IFN, and IL-7. J. Immunol. 186: 2106-2116.
44. Hellerstein, M. K., and J. M. McCune. 1997. T cell turnover in HIV-1 disease. Immunity 7: 583-589.
45. Kovacs, J. A., R. A. Lempicki, I. A. Sidorov, J. W. Adelsberger, B. Herpin, J. A. Metcalf, I. Sereti, M. A. Polis, R. T. Davey, J. Tavel, et al. 2001. Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV. J. Exp. Med. 194: 1731-1741.
46. Fleury, S., G. P. Rizzardi, A. Chapuis, G. Tambussi, C. Knabenhans, E. Simeoni, J. Y. Meuwly, J. M. Corpataux, A. Lazzarin, F. Miedema, and G. Pantaleo. 2000. Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 97: 5393-5398.
47. Mohri, H., S. Bonhoeffer, S. Monard, A. S. Perelson, and D. D. Ho. 1998. Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. Science 279: 1223-1227.
48. Mohri, H., A. S. Perelson, K. Tung, R. M. Ribeiro, B. Ramratnam, M. Markowitz, R. Kost, A. Hurley, L. Weinberger, D. Cesar, et al. 2001. Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J. Exp. Med. 194: 1277-1287.
49. Rosenzweig, M., M. A. DeMaria, D. M. Harper, S. Friedrich, R. K. Jain, and R. P. Johnson. 1998. Increased rates of CD4(+) and CD8(+) T lymphocyte turnover in simian immunodeficiency virus-infected macaques. Proc. Natl. Acad. Sci. USA 95: 6388-6393.
50. Gordon, S. N., B. Cervasi, P. Odorizzi, R. Silverman, F. Aberra, G. Ginsberg, J. D. Estes, M. Paiardini, I. Frank, and G. Silvestri. 2010. Disruption of intestinal CD4+ T cell homeostasis is a key marker of systemic CD4+ T cell activation in HIV-infected individuals. J. Immunol. 185: 5169-5179.
51. Acierno, P. M., D. A. Newton, E. A. Brown, L. A. Maes, J. E. Baatz, and S. Gattoni-Celli. 2003. Cross-reactivity between HLA-A2-restricted FLU-M1: 58-66 and HIV p17 GAG:77-85 epitopes in HIV-infected and uninfected individuals. J. Transl. Med. 1: 3.
52. Condotta, S. A., D. Rai, B. R. James, T. S. Griffith, and V. P. Badovinac. 2013. Sustained and incomplete recovery of naive CD8+ T cell precursors after sepsis contributes to impaired CD8+ T cell responses to infection. J. Immunol. 190: 1991-2000.
53. Mackall, C. L., T. A. Fleisher, M. R. Brown, M. P. Andrich, C. C. Chen, I. M. Feuerstein, I. T. Magrath, L. H. Wexler, D. S. Dimitrov, and R. E. Gress. 1997. Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 89: 3700-3707.
54. Srinivasula, S., R. A. Lempicki, J. W. Adelsberger, C. Y. Huang, J. Roark, P. I. Lee, A. Rupert, R. Stevens, I. Sereti, H. C. Lane, et al. 2011. Differential effects of HIV viral load and CD4 count on proliferation of naive and memory CD4 and CD8 T lymphocytes. Blood 118: 262-270.
55. Sieg, S. F., B. Rodriguez, R. Asaad, W. Jiang, D. A. Bazdar, and M. M. Lederman. 2005. Peripheral S-phase T cells in HIV disease have a central memory phenotype and rarely have evidence of recent T cell receptor engagement. J. Infect. Dis. 192: 62-70.
56. Tan, J. T., B. Ernst, W. C. Kieper, E. LeRoy, J. Sprent, and C. D. Surh. 2002. Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J. Exp. Med. 195: 1523-1532.
57. Cottalorda, A., B. C. Mercier, F. M. Mbitikon-Kobo, C. Arpin, D. Y. Teoh, A. McMichael, J. Marvel, and N. Bonnefoy-Bérard. 2009. TLR2 engagement on memory CD8(+) T cells improves their cytokine-mediated proliferation and IFN-gamma secretion in the absence of Ag. Eur. J. Immunol. 39: 2673-2681.
58. Komai-Koma, M., L. Jones, G. S. Ogg, D. Xu, and F. Y. Liew. 2004. TLR2 is expressed on activated T cells as a costimulatory receptor. Proc. Natl. Acad. Sci. USA 101: 3029-3034.
59. Caron, G., D. Duluc, I. Frémaux, P. Jeannin, C. David, H. Gascan, and Y. Delneste. 2005. Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells. J. Immunol. 175: 1551-1557.
60. Tough, D. F., S. Sun, and J. Sprent. 1997. T cell stimulation in vivo by lipopolysaccharide (LPS). J. Exp. Med. 185: 2089-2094.
61. Funderburg, N., A. A. Luciano, W. Jiang, B. Rodriguez, S. F. Sieg, and M. M. Lederman. 2008. Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis. PloS One. 3:e1915.
62. Avice, M. N., C. E. Demeure, G. Delespesse, M. Rubio, M. Armant, and M. Sarfati. 1998. IL-15 promotes IL-12 production by human monocytes via T cell-dependent contact and may contribute to IL-12-mediated IFN-gamma secretion by CD4+ T cells in the absence of TCR ligation. J. Immunol. 161: 3408-3415.
63. Dillon, S. M., K. B. Robertson, S. C. Pan, S. Mawhinney, A. L. Meditz, J. M. Folkvord, E. Connick, M. D. McCarter, and C. C. Wilson. 2008. Plasmacytoid and myeloid dendritic cells with a partial activation phenotype accumulate in lymphoid tissue during asymptomatic chronic HIV-1 infection. J. Acquir. Immune Defic. Syndr. 48: 1-12.
64. Almeida, M., M. Cordero, J. Almeida, and A. Orfao. 2005. Different subsets of peripheral blood dendritic cells show distinct phenotypic and functional abnormalities in HIV-1 infection. AIDS 19: 261-271.
65. Barron, M. A., N. Blyveis, B. E. Palmer, S. MaWhinney, and C. C. Wilson. 2003. Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals. J. Infect. Dis. 187: 26-37.
66. Di Domizio, J., A. Blum, M. Gallagher-Gambarelli, J. P. Molens, L. Chaperot, and J. Plumas. 2009. TLR7 stimulation in human plasmacytoid dendritic cells leads to the induction of early IFN-inducible genes in the absence of type I IFN. Blood 114: 1794-1802.
67. Nazli, A., O. Chan, W. N. Dobson-Belaire, M. Ouellet, M. J. Tremblay, S. D. Gray-Owen, A. L. Arsenault, and C. Kaushic. 2010. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog. 6: e1000852.
68. Quaranta, M. G., B. Camponeschi, E. Straface, W. Malorni, and M. Viora. 1999. Induction of interleukin-15 production by HIV-1 nef protein: a role in the proliferation of uninfected cells. Exp. Cell Res. 250: 112-121.
69. Facchetti, F., W. Vermi, D. Mason, and M. Colonna. 2003. The plasmacytoid monocyte/interferon producing cells. Virchows Arch. 443:703-717.
70. Fitzgerald-Bocarsly, P., and E. S. Jacobs. 2010. Plasmacytoid dendritic cells in HIV infection: striking a delicate balance. J. Leukoc. Biol. 87: 609-620.
71. Fonteneau, J. F., M. Larsson, A. S. Beignon, K. McKenna, I. Dasilva, A. Amara, Y. J. Liu, J. D. Lifson, D. R. Littman, and N. Bhardwaj. 2004. Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J. Virol. 78: 5223-5232.